|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1 Pt 1
|
|
pubmed:dateCreated |
1995-3-9
|
|
pubmed:abstractText |
The purpose of this study was to elucidate the maternal-fetal transfer of bisheteroypiperazine (U-87201-E), a nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus-1.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jan
|
|
pubmed:issn |
0002-9378
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
172
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
88-91
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
|
|
pubmed:year |
1995
|
|
pubmed:articleTitle |
The maternal-fetal transfer of bisheteroypiperazine (U-87201-E) in the ex vivo human placenta.
|
|
pubmed:affiliation |
Department of Obstetrics and Gynecology, University of Texas Southwestern Medical Center.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
